Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice

Petros Karakousis, Tetsuyuki Yoshimatsu, Gyanu Lamichhane, Samuel C. Woolwine, Eric Nuermberger, Jacques Grosset, William Ramses Bishai

Research output: Contribution to journalArticle

Abstract

Mycobacterium tuberculosis residing within pulmonary granulomas and cavities represents an important reservoir of persistent organisms during human latent tuberculosis infection. We present a novel in vivo model of tuberculosis involving the encapsulation of bacilli in semidiffusible hollow fibers that are implanted subcutaneously into mice. Granulomatous lesions develop around these hollow fibers, and in this microenvironment, the organisms demonstrate an altered physiologic state characterized by stationary-state colony-forming unit counts and decreased metabolic activity. Moreover, these organisms show an antimicrobial susceptibility pattern similar to persistent bacilli in current models of tuberculosis chemotherapy in that they are more susceptible to the sterilizing drug, rifampin, than to the bactericidal drug isoniazid. We used this model of extracellular persistence within host granulomas to study both gene expression patterns and mutant survival patterns. Our results demonstrate induction of dosR (Rv3133c) and 20 other members of the DosR regulon believed to mediate the transition into dormancy, and that relMtb is required for Mycobacterium tuberculosis survival during extracellular persistence within host granulomas. Interestingly, the dormancy phenotype of extracellular M. tuberculosis within host granulomas appears to be immune mediated and interferon-γ dependent.

Original languageEnglish (US)
Pages (from-to)647-657
Number of pages11
JournalJournal of Experimental Medicine
Volume200
Issue number5
DOIs
StatePublished - Sep 6 2004

Fingerprint

Granuloma
Mycobacterium tuberculosis
Phenotype
Bacillus
Tuberculosis
Latent Tuberculosis
Regulon
Survival
Isoniazid
Rifampin
Pharmaceutical Preparations
Interferon-gamma
Stem Cells
Gene Expression
Drug Therapy
Lung

Keywords

  • Antibiotics
  • Gene expression
  • Latency
  • Microarrays
  • Persistence

ASJC Scopus subject areas

  • Immunology

Cite this

Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice. / Karakousis, Petros; Yoshimatsu, Tetsuyuki; Lamichhane, Gyanu; Woolwine, Samuel C.; Nuermberger, Eric; Grosset, Jacques; Bishai, William Ramses.

In: Journal of Experimental Medicine, Vol. 200, No. 5, 06.09.2004, p. 647-657.

Research output: Contribution to journalArticle

@article{3bc2a95933fd4f15a95b09652e296252,
title = "Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice",
abstract = "Mycobacterium tuberculosis residing within pulmonary granulomas and cavities represents an important reservoir of persistent organisms during human latent tuberculosis infection. We present a novel in vivo model of tuberculosis involving the encapsulation of bacilli in semidiffusible hollow fibers that are implanted subcutaneously into mice. Granulomatous lesions develop around these hollow fibers, and in this microenvironment, the organisms demonstrate an altered physiologic state characterized by stationary-state colony-forming unit counts and decreased metabolic activity. Moreover, these organisms show an antimicrobial susceptibility pattern similar to persistent bacilli in current models of tuberculosis chemotherapy in that they are more susceptible to the sterilizing drug, rifampin, than to the bactericidal drug isoniazid. We used this model of extracellular persistence within host granulomas to study both gene expression patterns and mutant survival patterns. Our results demonstrate induction of dosR (Rv3133c) and 20 other members of the DosR regulon believed to mediate the transition into dormancy, and that relMtb is required for Mycobacterium tuberculosis survival during extracellular persistence within host granulomas. Interestingly, the dormancy phenotype of extracellular M. tuberculosis within host granulomas appears to be immune mediated and interferon-γ dependent.",
keywords = "Antibiotics, Gene expression, Latency, Microarrays, Persistence",
author = "Petros Karakousis and Tetsuyuki Yoshimatsu and Gyanu Lamichhane and Woolwine, {Samuel C.} and Eric Nuermberger and Jacques Grosset and Bishai, {William Ramses}",
year = "2004",
month = "9",
day = "6",
doi = "10.1084/jem.20040646",
language = "English (US)",
volume = "200",
pages = "647--657",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "5",

}

TY - JOUR

T1 - Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice

AU - Karakousis, Petros

AU - Yoshimatsu, Tetsuyuki

AU - Lamichhane, Gyanu

AU - Woolwine, Samuel C.

AU - Nuermberger, Eric

AU - Grosset, Jacques

AU - Bishai, William Ramses

PY - 2004/9/6

Y1 - 2004/9/6

N2 - Mycobacterium tuberculosis residing within pulmonary granulomas and cavities represents an important reservoir of persistent organisms during human latent tuberculosis infection. We present a novel in vivo model of tuberculosis involving the encapsulation of bacilli in semidiffusible hollow fibers that are implanted subcutaneously into mice. Granulomatous lesions develop around these hollow fibers, and in this microenvironment, the organisms demonstrate an altered physiologic state characterized by stationary-state colony-forming unit counts and decreased metabolic activity. Moreover, these organisms show an antimicrobial susceptibility pattern similar to persistent bacilli in current models of tuberculosis chemotherapy in that they are more susceptible to the sterilizing drug, rifampin, than to the bactericidal drug isoniazid. We used this model of extracellular persistence within host granulomas to study both gene expression patterns and mutant survival patterns. Our results demonstrate induction of dosR (Rv3133c) and 20 other members of the DosR regulon believed to mediate the transition into dormancy, and that relMtb is required for Mycobacterium tuberculosis survival during extracellular persistence within host granulomas. Interestingly, the dormancy phenotype of extracellular M. tuberculosis within host granulomas appears to be immune mediated and interferon-γ dependent.

AB - Mycobacterium tuberculosis residing within pulmonary granulomas and cavities represents an important reservoir of persistent organisms during human latent tuberculosis infection. We present a novel in vivo model of tuberculosis involving the encapsulation of bacilli in semidiffusible hollow fibers that are implanted subcutaneously into mice. Granulomatous lesions develop around these hollow fibers, and in this microenvironment, the organisms demonstrate an altered physiologic state characterized by stationary-state colony-forming unit counts and decreased metabolic activity. Moreover, these organisms show an antimicrobial susceptibility pattern similar to persistent bacilli in current models of tuberculosis chemotherapy in that they are more susceptible to the sterilizing drug, rifampin, than to the bactericidal drug isoniazid. We used this model of extracellular persistence within host granulomas to study both gene expression patterns and mutant survival patterns. Our results demonstrate induction of dosR (Rv3133c) and 20 other members of the DosR regulon believed to mediate the transition into dormancy, and that relMtb is required for Mycobacterium tuberculosis survival during extracellular persistence within host granulomas. Interestingly, the dormancy phenotype of extracellular M. tuberculosis within host granulomas appears to be immune mediated and interferon-γ dependent.

KW - Antibiotics

KW - Gene expression

KW - Latency

KW - Microarrays

KW - Persistence

UR - http://www.scopus.com/inward/record.url?scp=4544243679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4544243679&partnerID=8YFLogxK

U2 - 10.1084/jem.20040646

DO - 10.1084/jem.20040646

M3 - Article

VL - 200

SP - 647

EP - 657

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 5

ER -